Martina Maurelli, Giampiero Girolomoni, & Paolo Gisondi. (2023). Cost per responder of adalimumab biosimilars versus methotrexate in patients with psoriasis: A real-life experience. Taylor & Francis Group.
Chicago Style (17th ed.) CitationMartina Maurelli, Giampiero Girolomoni, and Paolo Gisondi. Cost Per Responder of Adalimumab Biosimilars Versus Methotrexate in Patients with Psoriasis: A Real-life Experience. Taylor & Francis Group, 2023.
MLA (9th ed.) CitationMartina Maurelli, et al. Cost Per Responder of Adalimumab Biosimilars Versus Methotrexate in Patients with Psoriasis: A Real-life Experience. Taylor & Francis Group, 2023.
Warning: These citations may not always be 100% accurate.